45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
1,531
Insurances with rates
1
CPT / HCPCS codes
1,394
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9228 | ipilimumab 200 mg/40 mL (5 mg/mL) Soln 40 mL VIAL | $63,953 | $44,767 | — | — | 1 |
| J3357 | Ustekinumab 90 mg/mL Syrg 1 mL SYRINGE | $50,154 | $35,108 | — | — | 1 |
| J2350 | ocrelizumab 30 mg/mL Soln 10 mL VIAL | $37,191 | $26,034 | — | — | 1 |
| J9309 | polatuzumab vedotin-piiq 140 mg Solr 1 Each VIAL | $33,538 | $23,476 | — | — | 1 |
| J9043 | cabazitaxel 10 mg/mL (first dilution) Soln 6 mL VIAL | $25,501 | $17,851 | — | — | 1 |
| J1628 | guselkumab 100 mg/mL Syrg 1 mL SYRINGE | $25,008 | $17,506 | — | — | 1 |
| 790 | HCHG LITHOTRIPSY CONTRACTED AFFILIATE ONLY | $24,920 | $17,444 | — | — | 1 |
| J9173 | durvalumab 50 mg/mL Soln 10 mL VIAL | $22,773 | $15,941 | — | — | 1 |
| J9042 | brentuximab vedotin 50 mg Solr 1 Each VIAL | $21,997 | $15,398 | — | — | 1 |
| J9347 | tremelimumab-actl 20 mg/mL Soln 15 mL VIAL | $18,296 | $12,807 | — | — | 1 |
| J9144 | daratumumab-hyaluronidase-fihj 1,800 mg-30,000 unit/15 mL Soln 15 mL VIAL | $18,078 | $12,654 | — | — | 1 |
| J3380 | vedolizumab 300 mg Solr 1 Each VIAL | $16,885 | $11,819 | — | — | 1 |
| J9316 | pertuzumab-trastuzumab-hyaluronidase-zzxf 600 mg-600 mg- 20000 unit/10mL Soln 10 mL VIAL | $16,736 | $11,715 | — | — | 1 |
| J9301 | obinutuzumab 1,000 mg/40 mL Soln 40 mL VIAL | $15,540 | $10,878 | — | — | 1 |
| J3101 | tenecteplase 50 mg Solr 1 Each VIAL | $14,972 | $10,480 | — | — | 1 |
| J9022 | atezolizumab 1,200 mg/20 mL (60 mg/mL) Soln 20 mL VIAL | $14,214 | $9,950 | — | — | 1 |
| J9023 | avelumab 20 mg/mL Soln 10 mL VIAL | $13,977 | $9,784 | — | — | 1 |
| J0402 | ARIPiprazole ER (2 month) 960 mg/3.2 mL Sers 3.2 mL SYRINGE | $13,941 | $9,759 | — | — | 1 |
| J9299 | nivolumab 240 mg/24 mL Soln 24 mL VIAL | $13,779 | $9,646 | — | — | 1 |
| J2406 | oritavancin 1,200 mg Solr 1 Each VIAL | $12,809 | $8,966 | — | — | 1 |
| J9303 | panitumumab 400 mg/20 mL (20 mg/mL) Soln 20 mL VIAL | $12,460 | $8,722 | — | — | 1 |
| J9311 | riTUXimab-hyaluronidase,human 1400 mg/11.7 mL (120 mg/mL) Soln 11.7 mL VIAL | $11,875 | $8,312 | — | — | 1 |
| J9354 | ado-trastuzumab emtansine 160 mg Solr 1 Each VIAL | $11,527 | $8,069 | — | — | 1 |
| J1162 | digoxin immune fab 40 mg Solr 1 Each VIAL | $11,479 | $8,035 | — | — | 1 |
| J2353 | octreotide,microspheres 20 mg Serr 1 Each VIAL | $11,079 | $7,755 | — | — | 1 |
| J0717 | Certolizumab Pegol 400 mg/2 mL (200 mg/mL x 2) Sykt 1 Each KIT | $10,836 | $7,585 | — | — | 1 |
| J9271 | pembrolizumab 25 mg/mL Soln 4 mL VIAL | $10,445 | $7,311 | — | — | 1 |
| 22513 | HCHG RAD KYPHOPLASTY THORACIC INCLUDING GUIDE | $10,435 | $7,305 | — | — | 1 |
| 22514 | HCHG RAD KYPHOPLASTY LUMBAR 1 LEVEL INCLUDING GUIDE | $10,435 | $7,305 | — | — | 1 |
| J9217 | leuprolide pediatric (1 month) 15 mg Kit 1 Each KIT | $9,903 | $6,932 | — | — | 1 |
| J1569 | immune globulin (human IGG) 10% (PF) 10 % Soln 300 mL VIAL | $9,466 | $6,626 | — | — | 1 |
| J2182 | mepolizumab 100 mg/mL Syrg 1 mL SYRINGE | $9,119 | $6,383 | — | — | 1 |
| J2802 | romiPLOStim 500 mcg Solr 1 Each VIAL | $9,052 | $6,337 | — | — | 1 |
| J1944 | ARIPiprazole lauroxil ER 1,064 mg/3.9 mL Sers 3.9 mL SYRINGE | $8,944 | $6,261 | — | — | 1 |
| J9057 | copanlisib 60 mg Solr 1 Each VIAL | $8,773 | $6,141 | — | — | 1 |
| J9312 | riTUXimab 10 mg/mL Conc 50 mL VIAL | $8,493 | $5,945 | — | — | 1 |
| J9356 | trastuzumab and hyaluronidase-oysk 600 mg-10,000 unit/5 mL Soln 5 mL VIAL | $8,452 | $5,917 | — | — | 1 |
| J1437 | ferric derisomaltose 100 mg iron/mL Soln 10 mL VIAL | $8,104 | $5,673 | — | — | 1 |
| Q5115 | riTUXimab-abbs 10 mg/mL Soln 50 mL VIAL | $7,647 | $5,353 | — | — | 1 |
| J0630 | calcitonin (salmon) 200 unit/mL Soln 2 mL VIAL | $7,517 | $5,262 | — | — | 1 |
| J9305 | PEMEtrexed disodium 500 mg Solr 1 Each VIAL | $7,314 | $5,120 | — | — | 1 |
| J3262 | tocilizumab 20 mg/mL Soln 20 mL VIAL | $7,208 | $5,045 | — | — | 1 |
| 78452 | HCHG RAD NM CARDIAC MYOCARD MULT SPECT WWO EF AND WM | $7,036 | $4,925 | — | — | 1 |
| J0565 | bezlotoxumab 25 mg/mL Soln 40 mL VIAL | $6,877 | $4,814 | — | — | 1 |
| 81455 | HCHG NGS 50 PLUS GENES | $6,765 | $4,736 | — | — | 1 |
| 770 | PR ANESTHESIA MAJOR ABDOMINAL BLOOD VESSELS | $6,517 | $4,562 | — | — | 0 |
| Q5123 | riTUXimab-arrx 10 mg/mL Soln 50 mL VIAL | $6,488 | $4,542 | — | — | 1 |
| J0139 | adalimumab 40 mg/0.8 mL Sykt 2 Each KIT | $6,267 | $4,387 | — | — | 1 |
| J9047 | carfilzomib 60 mg Solr 60 mg VIAL | $5,932 | $4,153 | — | — | 1 |
| J9400 | ziv-aflibercept 200 mg/8 mL (25 mg/mL) Soln 8 mL VIAL | $5,797 | $4,058 | — | — | 1 |
Showing top 50 of 1,531 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.